VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CORT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CORTCorcept Therapeutics Incorporated
$94.04$10.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCORTQuarterly Financials

Corcept Therapeutics Incorporated (CORT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Corcept Therapeutics Incorporated (CORT) quarterly income statement — complete revenue, gross profit & net income history

CORT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue164.9M202.13M207.64M194.43M157.21M181.89M182.55M163.8M146.81M135.41M123.6M117.72M105.65M103.06M101.73M103.39M93.69M98.82M96.13M91.59M
Revenue Growth %4.89%11.12%13.75%18.7%7.09%34.33%47.69%39.15%38.95%31.39%21.5%13.86%12.77%4.28%5.82%12.88%17.94%15.26%11.36%3.41%
Cost of Goods Sold2.88M2.54M4.6M3.43M2.4M2.96M2.87M2.52M2.54M1.88M1.65M1.57M1.39M1.48M1.34M1.32M1.25M1.35M1.27M1.38M
COGS % of Revenue1.75%1.26%2.21%1.77%1.53%1.63%1.57%1.54%1.73%1.39%1.33%1.34%1.31%1.44%1.32%1.27%1.33%1.37%1.33%1.51%
Gross Profit162.02M199.58M203.04M191M154.81M178.93M179.68M161.27M144.27M133.53M121.96M116.14M104.27M101.58M100.39M102.07M92.44M97.47M94.86M90.2M
Gross Margin %98.25%98.74%97.79%98.23%98.47%98.37%98.43%98.46%98.27%98.61%98.67%98.66%98.69%98.56%98.68%98.73%98.67%98.63%98.67%98.49%
Gross Profit Growth %4.66%11.54%13%18.43%7.3%34%47.33%38.86%38.37%31.46%21.48%13.79%12.8%4.21%5.83%13.15%18.25%15.37%11.45%3.29%
Operating Expenses211.62M195.09M192.82M164.32M151.4M153.67M133.08M125.68M114.77M101.86M90.78M86.56M89.42M79.08M68.45M70.64M65.67M60.8M58.62M58.26M
OpEx % of Revenue128.33%96.52%92.86%84.51%96.3%84.49%72.9%76.73%78.18%75.23%73.45%73.53%84.63%76.73%67.29%68.32%70.09%61.53%60.98%63.61%
Selling, General & Admin145.36M130.24M123.98M103.85M90.66M83.37M73.75M66.94M56.27M47.15M45.26M43.28M48.56M42.32M35.16M37.81M37.55M32.28M30.53M30.03M
SG&A % of Revenue88.15%64.43%59.71%53.41%57.67%45.84%40.4%40.86%38.33%34.82%36.62%36.77%45.97%41.07%34.57%36.57%40.08%32.67%31.76%32.79%
Research & Development66.27M64.86M68.85M60.47M60.73M70.3M59.34M58.74M58.51M54.71M45.52M43.28M40.85M36.75M33.29M32.83M28.12M28.52M28.09M28.23M
R&D % of Revenue40.18%32.09%33.16%31.1%38.63%38.65%32.5%35.86%39.85%40.4%36.83%36.76%38.66%35.66%32.73%31.75%30.01%28.86%29.22%30.83%
Other Operating Expenses0100000500K000000000000
Operating Income-49.6M4.49M10.22M26.68M3.42M25.26M46.6M35.59M29.5M31.67M31.18M29.58M14.85M22.5M31.93M31.43M26.77M36.66M36.23M31.94M
Operating Margin %-30.08%2.22%4.92%13.72%2.17%13.89%25.53%21.73%20.09%23.39%25.22%25.13%14.06%21.83%31.39%30.4%28.57%37.1%37.69%34.88%
Operating Income Growth %-1552.02%-82.24%-78.07%-25.05%-88.42%-20.23%49.46%20.31%98.61%40.76%-2.37%-5.88%-44.51%-38.63%-11.86%-1.6%36.31%20.17%46.58%-9.41%
EBITDA-49.6M4.97M10.7M27.14M3.88M25.72M47.1M35.85M29.62M32.24M31.47M29.89M15.14M23.25M32.69M32.1M27.57M37.46M37M32.7M
EBITDA Margin %-30.08%2.46%5.15%13.96%2.47%14.14%25.8%21.89%20.18%23.81%25.46%25.39%14.33%22.56%32.13%31.05%29.43%37.91%38.49%35.7%
EBITDA Growth %-1379.04%-80.68%-77.29%-24.28%-86.91%-20.22%49.68%19.94%95.59%38.69%-3.73%-6.89%-45.07%-37.95%-11.67%-1.83%35.28%20.56%46.36%-8.59%
D&A (Non-Cash Add-back)0482K477K469K462K460K499K257K120K572K289K305K291K747K752K668K802K797K771K756K
EBIT-49.6M4.49M10.22M26.68M3.42M25.26M46.6M41.6M29.5M31.67M31.18M29.58M14.85M22.5M31.93M31.43M26.77M36.66M36.23M31.94M
Net Interest Income000006.7M6.34M6M5.49M5.14M5.21M3.35M3.58M1.78M1.07M630K80K72K72K110K
Interest Income000006.7M6.34M6M5.49M5.14M5.21M3.35M3.58M1.78M1.07M630K80K72K72K110K
Interest Expense00000000000000000000
Other Income/Expense4.89M5.42M5.02M5.02M6.2M6.7M6.34M6M5.49M5.14M5.21M3.35M3.58M1.78M1.07M630K80K72K72K110K
Pretax Income-44.72M9.91M15.24M31.69M9.62M31.96M52.94M41.6M34.99M36.81M36.38M32.93M18.43M24.28M33M32.06M26.85M36.74M36.3M32.05M
Pretax Margin %-27.12%4.9%7.34%16.3%6.12%17.57%29%25.39%23.84%27.18%29.44%27.97%17.45%23.56%32.44%31.01%28.66%37.17%37.77%35%
Income Tax-13.51M-14.38M-4.42M-3.46M-10.93M1.21M5.73M6.11M7.23M5.45M5.01M5.4M2.56M7.67M-1.6M4.65M4.05M4.68M5.83M5.53M
Effective Tax Rate %30.22%-145.09%-29.03%-10.91%-113.63%3.8%10.82%14.68%20.66%14.82%13.76%16.4%13.86%31.62%-4.86%14.5%15.09%12.75%16.07%17.25%
Net Income-31.2M24.29M19.67M35.15M20.55M30.39M46.69M35.49M27.76M31.36M31.38M27.53M15.88M16.6M34.61M27.41M22.8M32.05M30.47M26.52M
Net Margin %-18.92%12.02%9.47%18.08%13.07%16.71%25.58%21.67%18.91%23.16%25.39%23.39%15.03%16.11%34.02%26.51%24.33%32.44%31.7%28.96%
Net Income Growth %-251.86%-20.08%-57.88%-0.96%-25.99%-3.08%48.8%28.92%74.83%88.87%-9.33%0.42%-30.35%-48.21%13.58%3.35%-2.85%23.31%40.91%-6.37%
Net Income (Continuing)-31.2M24.29M19.67M35.15M20.55M30.75M47.21M35.49M27.76M31.36M31.38M27.53M15.88M16.6M34.61M27.41M22.8M32.05M30.47M26.52M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.300.200.160.290.170.260.410.320.250.280.280.250.140.140.300.240.200.260.240.21
EPS Growth %-276.47%-23.08%-60.98%-9.38%-32%-7.14%46.43%28%78.57%100%-6.67%4.17%-30%-46.15%25%14.29%11.11%30%41.18%-8.7%
EPS (Basic)-0.300.230.190.330.190.290.450.340.270.300.310.270.150.150.300.240.200.280.260.23
Diluted Shares Outstanding104.44M119.86M119.44M120.48M119.82M118.46M113.72M111.24M109.92M110.89M111.1M109.59M115.42M116.33M116.62M115.4M115.04M122.43M125.14M126.68M
Basic Shares Outstanding104.44M103.69M103.55M104.11M104.11M103.64M103.37M103.12M102.79M102.45M102.01M101.96M107.89M107.7M115.17M114.16M113.98M113.74M115.79M116.29M
Dividend Payout Ratio--------------------